Iom Bioworks, a deep science company pioneering microbiome-focused healthcare, has raised ₹4.2 crore in its seed funding round led by Inflection Point Ventures (IPV).
The funds raised will be used for marketing, securing intellectual property claims, strengthening core infrastructure and scaling scientific and commercial teams.
Founded in 2022 by Bipin Pradeep Kumar, Dr. Samik Ghosh, and Dr. Hiroaki Kitano, Iom Bioworks personalises health by identifying key bacteria in the gut and modulating them in a targeted manner for enhanced, improved overall health and well-being.
Their patented platform combines large-scale knowledge graphed mined through Artificial Intelligence (AI) and advanced modelling techniques that ensure Iom achieves precise and personalized recommendations for its users.
Iom Bioworks have reached more than 500 customers in just the first year and have 2 patents granted and 2 in advanced stages. They have key scientific publications in leading scientific journals. Iom Bioworks have Pan India logistics and have established digital access established for personalised microbiome services.
Bipin Pradeep Kumar, Co-Founder and CEO, Iom Bioworks, said, “Iom Bioworks envisions a world where a healthy mind and body are achievable through informed choices that nurture the microbiome. By empowering our inner ecosystem through prebiotics and a food and lifestyle centred around the bacteria, we aim to energize daily life while preserving the joy of living. Partnering with IPV has been transformative; their supportive and diligent approach has set us firmly on the path toward this vision.”
Vinay Bansal, Founder, IPV, said, “Lifestyle diseases have been on the rise due to multiple reasons like poor diet, stress, lack of sleep and are intimately linked to poor gut health and microbial composition. The gut microbiome plays a huge role in your digestion, immunity, metabolism, and even mood. Understanding it can help prevent a myriad of these diseases and also provide a better quality of life. Iom Bioworks is making this cutting-edge science accessible, personalised and importantly, actionable. With their vision and science, they make a compelling bet in preventive and therapeutic healthcare.”
